美國Genpathway  www.genpathway.com
Genpathway公司是市場上提供ChIP和DNA甲基化分析的領(lǐng)先者，并提供鑒定和分析轉(zhuǎn)錄因子和外界變化對基因的調(diào)控、基因轉(zhuǎn)錄和它們相關(guān)的信號通路的服務。這些Genpathway提供的分析和服務，可以幫助制藥和生物技術(shù)公司來發(fā)現(xiàn)和檢驗新藥、生物標記物和診斷試驗，以及科研、政府研究院和農(nóng)業(yè)公司。

Genpathway is an early-stage pharmacogenomics company that provides specialized drug and biomarker discovery services and develops novel diagnostic biomarkers that predict drug responses, enabling personalized treatments. The company applies its proprietary chromatin and methylated DNA immunoprecipitation sequencing (ChIP-Seq) technology to understand gene regulation and genetic pathways by studying transcription factor binding, gene transcription, and epigenetic events such as DNA methylation and histone modifications. Based on the information gained from its platform technology, Genpathway intends to develop and commercialize a broad portfolio of clinically validated molecular diagnostic products and services that will enable the accurate selection of specific drugs to efficaciously treat individuals with cancer, immune disorders, and other serious diseases.